Cargando…

Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016

Hepatitis C virus (HCV) infection is a leading cause of liver‐related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demographic disparities and targeted efforts to reduce preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Heather, Hall, Eric W., Rosenthal, Elizabeth M., Sullivan, Patrick S., Ryerson, A. Blythe, Rosenberg, Eli S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049678/
https://www.ncbi.nlm.nih.gov/pubmed/32140654
http://dx.doi.org/10.1002/hep4.1457
_version_ 1783502488999034880
author Bradley, Heather
Hall, Eric W.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Ryerson, A. Blythe
Rosenberg, Eli S.
author_facet Bradley, Heather
Hall, Eric W.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Ryerson, A. Blythe
Rosenberg, Eli S.
author_sort Bradley, Heather
collection PubMed
description Hepatitis C virus (HCV) infection is a leading cause of liver‐related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demographic disparities and targeted efforts to reduce prevalence in populations with disproportionate disease rates. We modeled state‐level estimates of hepatitis C prevalence among U.S. adults by sex, birth cohort, and race during 2013‐2016. National Health and Nutrition Examination Survey data were used in combination with state‐level HCV‐related and narcotic overdose–related mortality data from the National Vital Statistics System and estimates from external literature review on populations not sampled in the National Health and Nutrition Examination Survey. Nationally, estimated hepatitis C prevalence was 1.3% among males and 0.6% among females (prevalence ratio [PR] = 2.3). Among persons born during 1945 to 1969, prevalence was 1.6% compared with 0.5% among persons born after 1969 (PR = 3.2). Among persons born during 1945 to 1969, prevalence ranged from 0.7% in North Dakota to 3.6% in Oklahoma and 6.8% in the District of Columbia. Among persons born after 1969, prevalence was more than twice as high in Kentucky, New Mexico, Oklahoma, and West Virginia compared with the national average. Hepatitis C prevalence was 1.8% among non‐Hispanic black persons and 0.8% among persons of other races (PR = 2.2), and the magnitude of this disparity varied widely across jurisdictions (PR range: 1.3‐7.8). Overall, 23% of prevalent HCV infections occurred among non‐Hispanic black persons, whereas 12% of the population was represented by this racial group. These estimates provide information on prevalent HCV infections that jurisdictions can use for understanding and monitoring local disease patterns and racial disparities in burden of disease.
format Online
Article
Text
id pubmed-7049678
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70496782020-03-05 Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016 Bradley, Heather Hall, Eric W. Rosenthal, Elizabeth M. Sullivan, Patrick S. Ryerson, A. Blythe Rosenberg, Eli S. Hepatol Commun Original Articles Hepatitis C virus (HCV) infection is a leading cause of liver‐related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demographic disparities and targeted efforts to reduce prevalence in populations with disproportionate disease rates. We modeled state‐level estimates of hepatitis C prevalence among U.S. adults by sex, birth cohort, and race during 2013‐2016. National Health and Nutrition Examination Survey data were used in combination with state‐level HCV‐related and narcotic overdose–related mortality data from the National Vital Statistics System and estimates from external literature review on populations not sampled in the National Health and Nutrition Examination Survey. Nationally, estimated hepatitis C prevalence was 1.3% among males and 0.6% among females (prevalence ratio [PR] = 2.3). Among persons born during 1945 to 1969, prevalence was 1.6% compared with 0.5% among persons born after 1969 (PR = 3.2). Among persons born during 1945 to 1969, prevalence ranged from 0.7% in North Dakota to 3.6% in Oklahoma and 6.8% in the District of Columbia. Among persons born after 1969, prevalence was more than twice as high in Kentucky, New Mexico, Oklahoma, and West Virginia compared with the national average. Hepatitis C prevalence was 1.8% among non‐Hispanic black persons and 0.8% among persons of other races (PR = 2.2), and the magnitude of this disparity varied widely across jurisdictions (PR range: 1.3‐7.8). Overall, 23% of prevalent HCV infections occurred among non‐Hispanic black persons, whereas 12% of the population was represented by this racial group. These estimates provide information on prevalent HCV infections that jurisdictions can use for understanding and monitoring local disease patterns and racial disparities in burden of disease. John Wiley and Sons Inc. 2020-01-14 /pmc/articles/PMC7049678/ /pubmed/32140654 http://dx.doi.org/10.1002/hep4.1457 Text en © 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Bradley, Heather
Hall, Eric W.
Rosenthal, Elizabeth M.
Sullivan, Patrick S.
Ryerson, A. Blythe
Rosenberg, Eli S.
Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title_full Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title_fullStr Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title_full_unstemmed Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title_short Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013‐2016
title_sort hepatitis c virus prevalence in 50 u.s. states and d.c. by sex, birth cohort, and race: 2013‐2016
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049678/
https://www.ncbi.nlm.nih.gov/pubmed/32140654
http://dx.doi.org/10.1002/hep4.1457
work_keys_str_mv AT bradleyheather hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016
AT hallericw hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016
AT rosenthalelizabethm hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016
AT sullivanpatricks hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016
AT ryersonablythe hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016
AT rosenbergelis hepatitiscvirusprevalencein50usstatesanddcbysexbirthcohortandrace20132016